Crescita Therapeutics Inc. (TSX:CTX)
Canada · Delayed Price · Currency is CAD 0.7900
0.00 (0.00%)
Inactive · Last trade price on Jun 4, 2026
Crescita Therapeutics Income Statement
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 23.22 | 21.12 | 19.58 | 17.52 | 23.53 | 16.77 | |
Revenue Growth | 28.13% | 7.85% | 11.74% | -25.52% | 40.29% | 7.22% |
Cost of Revenue | 11.04 | 10.01 | 10.59 | 7.16 | 10.34 | 6.76 |
Gross Profit | 12.18 | 11.11 | 8.99 | 10.36 | 13.18 | 10.01 |
Selling, General & Admin | 12.01 | 10.82 | 10.81 | 10.12 | 10.57 | 9.5 |
Research & Development | 0.58 | 0.57 | 0.65 | 0.7 | 0.61 | 0.63 |
Operating Expenses | 13.35 | 12.13 | 12.21 | 12.32 | 12.65 | 11.51 |
Operating Income | -1.17 | -1.02 | -3.22 | -1.96 | 0.53 | -1.5 |
Interest Expense | -0.06 | -0.04 | -0.07 | -0.09 | -0.16 | -0.24 |
Interest & Investment Income | 0.29 | 0.33 | 0.5 | 0.51 | 0.26 | 0.18 |
Earnings From Equity Investments | -0.02 | -0.03 | -0.05 | 0.02 | -0.06 | 0.01 |
Currency Exchange Gain (Loss) | 0.12 | 0.16 | -0.04 | 0.01 | -0.05 | -0.24 |
Other Non Operating Income (Expenses) | 1.47 | 1.47 | - | - | - | - |
EBT Excluding Unusual Items | 0.64 | 0.86 | -2.87 | -1.51 | 0.52 | -1.79 |
Gain (Loss) on Sale of Investments | -0.28 | -0.28 | - | - | - | - |
Other Unusual Items | -0.67 | -0.67 | 0.11 | -0.02 | -0.12 | 0.78 |
Pretax Income | -0.31 | -0.08 | -2.76 | -1.53 | 0.4 | -1.01 |
Income Tax Expense | 0.01 | 0.01 | -0.01 | 0.46 | -0.46 | 0.1 |
Earnings From Continuing Operations | -0.32 | -0.09 | -2.75 | -1.99 | 0.86 | -1.11 |
Net Income | -0.32 | -0.09 | -2.75 | -1.99 | 0.86 | -1.11 |
Net Income to Common | -0.32 | -0.09 | -2.75 | -1.99 | 0.86 | -1.11 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 19 | 19 | 19 | 20 | 21 | 21 |
Shares Outstanding (Diluted) | 19 | 19 | 19 | 20 | 21 | 21 |
Shares Change | -2.43% | -2.61% | -4.44% | -3.55% | 1.18% | -1.02% |
EPS (Basic) | -0.02 | -0.00 | -0.14 | -0.10 | 0.04 | -0.05 |
EPS (Diluted) | -0.02 | -0.00 | -0.14 | -0.10 | 0.04 | -0.05 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 0.67 | -0.04 | 0.63 | 1.94 | -1.25 | -1.94 |
Free Cash Flow Per Share | 0.04 | -0.00 | 0.03 | 0.10 | -0.06 | -0.09 |
Gross Margin | 52.47% | 52.60% | 45.91% | 59.15% | 56.03% | 59.72% |
Operating Margin | -5.02% | -4.84% | -16.42% | -11.16% | 2.25% | -8.92% |
Profit Margin | -1.38% | -0.44% | -14.04% | -11.33% | 3.66% | -6.59% |
Free Cash Flow Margin | 2.88% | -0.17% | 3.21% | 11.09% | -5.31% | -11.59% |
EBITDA | -0.07 | 0.04 | -2.27 | -0.86 | 1.61 | -0.48 |
EBITDA Margin | -0.28% | 0.21% | -11.61% | -4.89% | 6.86% | -2.86% |
D&A For EBITDA | 1.1 | 1.07 | 0.94 | 1.1 | 1.08 | 1.02 |
EBIT | -1.17 | -1.02 | -3.22 | -1.96 | 0.53 | -1.5 |
EBIT Margin | -5.02% | -4.84% | -16.42% | -11.16% | 2.25% | -8.92% |